Literature DB >> 22694289

Light deficiency confers breast cancer risk by endocrine disorders.

Zsuzsanna Suba1.   

Abstract

North-America and northern European countries exhibit the highest incidence rate of breast cancer, whereas women in southern regions are relatively protected. Immigrants from low cancer incidence regions to high-incidence areas might exhibit similarly higher or excessive cancer risk as compared with the inhabitants of their adoptive country. Additional cancer risk may be conferred by incongruence between their biological characteristics and foreign environment. Many studies established the racial/ethnic disparities in the risk and nature of female breast cancer in United States between African-American and Caucasian women. Mammary tumors in black women are diagnosed at earlier age, and are associated with higher rate of mortality as compared with cancers of white cases. Results of studies on these ethnic/racial differences in breast cancer incidence suggest that excessive pigmentation of dark skinned women results in a relative light-deficiency. Poor light exposure may explain the deleterious metabolic and hormonal alterations; such as insulin resistance, deficiencies of estrogen, thyroxin and vitamin-D conferring excessive cancer risk. The more northern the location of an adoptive country the higher the cancer risk for dark skinned immigrants. Recognition of the deleterious systemic effects of darkness and excessive melatonin synthesis enables cancer protection treatment for people living in light-deficient environment. Recent patents provide new methods for the prevention of hormonal and metabolic abnormities.

Entities:  

Mesh:

Year:  2012        PMID: 22694289     DOI: 10.2174/157489212801820048

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  4 in total

1.  Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implications.

Authors:  Zsuzsanna Suba
Journal:  Onco Targets Ther       Date:  2014-01-23       Impact factor: 4.147

Review 2.  Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2016       Impact factor: 4.169

Review 3.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

Review 4.  Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.

Authors:  Zsuzsanna Suba
Journal:  Drug Des Devel Ther       Date:  2014-09-11       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.